Drug class
Glycosaminoglycan
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
Home→ERA Profiles → Pentosan Polysulfate→
Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
Sources: FDA product information
Glycosaminoglycan
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
The pathway is agreed for the medicinal product, intended market, use assumptions and available environmental evidence.
ReguSight provides project-specific support for the Pentosan Polysulfate Environmental Risk Assessment (ERA) (the Pentosan Polysulfate ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.